CHI to Debut Drug Delivery & Formulation Meeting at World Pharma Congress 2013

The Accelerating Development of Difficult-to-Deliver Drugs conference will discuss the role of novel delivery strategies and advanced tools in developing difficult-to-deliver drugs.
Spread the Word
Listed Under

* Drug Formulation
* Nanodelivery

* Biotech
* Science

* Needham - Massachusetts - US

Feb. 22, 2013 - PRLog -- Cambridge Healthtech Institute will debut its inaugural Accelerating Development of Difficult-to-Deliver Drugs conference at the 12th annual World Pharma Congress.  Taking place June 4-6 in Philadelphia, PA, this conference will discuss the role of novel delivery strategies and advanced tools in developing difficult-to-deliver drugs, designing targeted delivery approaches, improving efficacy and safety, and leading to overall patient compliant therapies.

Formulation and Drug Delivery thought-leaders from both pharma and academia will present latest research, developments, and expertise in aspects of drug delivery including nanotechnology, nanoparticles, bioavailability, next-gen protein delivery, and more.

The distinguished faculty at this conference includes:

- Vladimir Torchilin, Ph.D., D.Sc., University Distinguished Professor, Department of Pharmaceutical Sciences, School of Pharmacy, Northeastern University

- Philip S. Low, Ph.D., Ralph C. Corley Distinguished Professor, Department of Chemistry, Purdue University

- Munir Hussain, Ph.D., Distinguished Research Fellow, Drug Product Science & Technology, Bristol-Myers Squibb Co.

- Anil K. Patri, Ph.D., Deputy Director, Nanotechnology Characterization, Laboratory, Advanced Technology Program, SAIC-Frederick, Inc.,National Laboratory for Cancer Research

- Uma Prabhakar, Ph.D., Consultant, Office of Cancer Nanotechnology Research NCI-NIH

- Karyn O’Neil, Ph.D., Chief Scientific Officer of Centyrex Venture, Johnson & Johnson

- Jeff Hrkach, Ph.D.  Vice President, R & D, Bind Bio Science

- Samir Mitragotri, Ph.D., Professor, Chemical Engineering, University of California, Santa Barbara

- Bobby Singh, Ph.D., Chief Technology Officer, Corium International, Inc.

- Karim Dabbagh, Ph.D., Executive Director and Head, External R&D and Innovation Research Units, Pfizer Worldwide R&D

- Tycho Heimbach, Ph.D., Associate Director & Senior Investigator II, Biomedical Research, Novartis Pharmaceuticals Corporation

- And more!

Why Should Scientists and Executives Interested in Drug Delivery Attend This Conference?

- Join in discussions and learn practical strategies from distinguished professors and industry experts from NCI-NIH, BMS, Merck, Novartis, J& J, BIND Biosciences, BI, Cubist and more.

- Hear case studies and novel approaches in Preformulation, drug targeting and next gen delivery of biologics

- Learn how to overcome the bioavailability hurdles for poorly soluble drugs with new technologies and tools.

The final agenda is set, and is available online at  There is an early registration discount of up to $350 available until March 1.
Email:*** Email Verified
Tags:Drug Formulation, Nanodelivery
Industry:Biotech, Science
Location:Needham - Massachusetts - United States
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
Cambridge Healthtech Institute News
Daily News
Weekly News

Like PRLog?
Click to Share